UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000034373
Receipt No. R000039186
Scientific Title A phase II, multicenter study to investigate the safety and efficacy of atezolizumab monotherapy as a sequential therapy following chemoradiotherapy in patients with locally advanced unresectable esophageal cancer
Date of disclosure of the study information 2018/11/01
Last modified on 2019/01/07 09:31:15

No. Disposal Last modified on Item of update
1 Insert 2018/10/04 10:41:43
2 Update 2018/10/05 10:40:50 UMIN ID1
3 Update 2019/01/07 09:31:15 Recruitment status


Contact us.